Moderator: Richard Knight, AAKP President, former dialysis patient, current transplant recipient
Speaker: Ivonne H. Schulman, MD, Program Director, Translational and Clinical Studies of Acute Kidney Injury; National Institutes of Health (NIH); National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK); Division of Kidney, Urologic and Hematologic Diseases (KUH)
Session sponsored by Mallinckrodt Pharmaceuticals
As the oldest and largest, independent kidney patient organization in the U.S. – AAKP is dedicated to improving the lives and long-term outcomes of kidney patients through education, advocacy, patient engagement and the fostering of patient communities. AAKP fights for early disease detection and the appropriate diagnosis of rare/genetic conditions; increased kidney transplantation and pre-emptive transplantation; full patient choice of either in-center or home dialysis; protection of the patient/physician relationship; promotion of research and innovation including artificial implantable and wearable kidneys; and the elimination of barriers for patient access to available treatment options. Learn more at www.aakp.org.
